O le EaseVRx ose masini fa'afoma'i fa'atalavai fa'atasi ai ma mea fa'apolokalame fa'apipi'i muamua i luga o se masini fa'apitoa e tu'uina atu a'oa'oga mo le puleaina o tiga e fa'atatau i tomai tau le mafaufau ma isi auala tau amio. O lo'o fa'aaogaina se faiga fa'atofu fa'atekonolosi (VR) e tu'uina atu ai le VR a'o fa'aulufaleina a'oa'oga o le tiga o le biopsychosocial, a'oa'oga manava manava, fa'amalositino mafaufau, fa'agasolo-tali fa'amalositino ma ta'aloga fa'atonu.

O le EaseVRx software content e aofia ai le valu vaiaso, VR-based program e fesoasoani i tagata e faʻaitiitia le faʻamaʻi ma le aʻafiaga o latou tiga. O tagata e maua i le tiga maualalo maualalo e mulimuli i le falemaʻi faʻamaonia, faʻavae faʻamaoniga polokalame e atiaʻe ai tomai faʻafetaui aʻo faia foi ni masaniga fou, fesoasoani e mafai ona faʻaitiitia ai le tiga ma le faʻalavelave tiga.

"O le aso nei o le faʻatagaina o le FDA e faʻailogaina ai se aso faʻapitoa mo AppliedVR, mo le vaega faʻafomaʻi faʻafomaʻi ma, sili ona taua, mo na tagata o loʻo mafatia i tiga masani o tua," o le tala lea a Matthew Stoudt, faʻavae ma Pule Sili o AppliedVR. "O tiga maualalo maualalo e mafai ona avea o se faʻafitauli faʻavaivaia ma taugata tele, ae o lea ua tasi le laʻasaga latalata atu i le ausiaina o la matou sini o le faia o togafitiga faʻatoto ma tulaga o le tausiga o tiga."

O le talosaga a le AppliedVR a le FDA na lagolagoina e ni fa'ata'ita'iga fa'atonutonu e lua (RCTs), e iloilo ai le aoga o se polokalame fa'avae VR mo le togafitia o le tiga tumau i le fale. O suʻesuʻega uma e lua na faʻamaonia ai o se polokalame faʻapitoa e faʻaaogaina e le tagata lava ia, faʻavae VR togafitiga e le gata o se auala talafeagai ma faʻaleleia e togafitia ai le tiga tumau, ae sa aoga foi i le faʻaleleia atili o le tele o tiga masani.

O le suʻesuʻega muamua, lomia i le JMIR Formative Research, suʻesuʻeina faʻamatalaga mai tagata o loʻo mafatia i le faʻamaʻi maualalo poʻo le fibromyalgia tiga i luga ole 21 aso. O tagata auai e faʻaaogaina le EaseVRx na faʻaitiitia ai faʻailoga autu e lima - o ia mea uma na ausia pe sili atu i le 30-pasene faʻamau mo le aoga o le falemaʻi.

I lana RCT taua o le suʻesuʻeina o le saogalemu ma le aoga o EaseVRx i luga o le valu vaiaso, o tagata auai i le vaega o le EaseVRx i le averesi na lipotia mai le tele o faʻaleleia i le maeʻa o togafitiga, e aofia ai le 42% faʻaitiitia o le tiga; 49% fa'aitiitiga fa'alavelave fa'alavelave; 52% faʻaitiitia i le faʻalavelave moe; 56% faʻaititia o le faʻalavelave faʻalavelave; ma le 57% faʻaititia i le faʻalavelave faʻalavelave.

E taua tele fa'amaumauga o feso'ota'iga ma fa'aoga i tagata e tu'uina atu ma totogi e tatau ona iloilo le fa'amoemoe e fa'aogaina e sui/ma'i se togafiti fa'atekinolosi - aemaise lava i latou i fafo atu o falema'i. I le suʻesuʻega taua, na faʻaalia e le au auai o le EaseVRx le maualuga o le faʻaogaina ma le averesi o le maeʻa o 5.4 vasega i le vaiaso ma faʻaalia le faamalieina i le faigofie o le faʻaogaina i luga o le System Usability Scale (faʻavasegaina le masini e faigofie ona faʻaoga nai lo le ATM ma luga ole imeli auaunaga).

"Sa matou galulue ma le le vaivai i nai tausaga ua tuanaʻi e fausia se tino e le mafaatusalia o faʻamaoniga faʻapitoa e faʻaalia ai le malosi o le VR mo le togafitia o tiga, ma e le mafai ona sili atu le fiafia e ausia lenei tulaga taua," o le tala lea a Josh Sackman, AppliedVR co- na faavaeina ma peresitene. “Ae, e le muta la tatou misiona i lenei faamaoniga e tasi. Matou te tuuto atu i le faʻaauauina o suʻesuʻega e faʻamaonia ai lo matou aoga ma le taugofie mo le togafitia o tiga masani ma isi faʻailoga.

O tiga maualalo maualalo o se tasi lea o tulaga masani masani o loʻo feagai ma tagata i le lalolagi atoa ma faʻatusalia se tasi o mafuaʻaga sili e misi ai e tagata galuega. E le gata i lea, o se faʻafitauli sili ona taugata mo tagata inisiua ona o le toʻatele o loʻo vaʻavaʻai e faʻaitiitia tau e fesoʻotaʻi ma taotoga tua. O suʻesuʻega talu ai nei na faʻaalia ai, pe a tuʻufaʻatasia ma le tiga o le ua, o le tiga pito i lalo e tau toeitiiti atoa le $ 77 piliona i inisiua tumaoti, $ 45 piliona i inisiua a le malo, ma le $ 12 piliona i fafo atu o le tupe mo tagata gasegase.

O tiga tumau, e sili atu ona lautele, e taugata ma fesoasoani i isi faʻafitauli o le soifua maloloina, e aofia ai le faʻamaʻi o le opioid. O se suʻesuʻega muamua a Johns Hopkins i le Journal of Pain na maua ai o le tiga tumau e mafai ona faʻaputuina le tau e oʻo atu i le $ 635 piliona i le tausaga - sili atu nai lo le tau o le kanesa, fatu fatu ma le maʻisuka tuʻufaʻatasia.

"O le tiga e masani ona togafitia i se faiga faʻapitoa faʻapitoa faʻatasi ma vaega taua o le tiga e leʻi togafitia," o le tala lea a Dr. Beth Darnall, Faufautua Sili Faʻasaienisi AppliedVR ma Stanford Saienitisi tiga. "O a matou suʻesuʻega o loʻo faʻaalia ai e mafai e le VR ona fuaina le lelei o le 'tagata atoa' tausiga tiga masani e mafai e tagata ona faʻaoga lelei i le mafanafana o latou lava fale. I le avea ai ma taʻitaʻi faʻaulufale faʻatekonolosi, AppliedVR ua sili ona lelei le tulaga e faʻatautaia ai se suiga faʻataʻitaʻiga i le tausiga o tiga.

I le maeʻa ai o lana faʻatagaina muamua a le FDA, ua fuafua le AppliedVR e faʻaauau suʻega e faʻaalia ai le aoga o le falemaʻi ma le taugata o le faʻaaogaina o le VR e togafitia ai tiga, aemaise lava le faʻamaeʻaina o le tele o suʻesuʻega tau soifua maloloina ma taunuʻuga (HEOR) ma tagata fai pisinisi. AppliedVR o loʻo galulue faʻatasi nei ma Geisinger ma Cleveland Clinic e faʻagasolo faʻataʻitaʻiga faʻapitoa faʻapitoa faʻapitoa a le NIDA e faʻataʻitaʻiina ai le VR o se mea faigaluega faʻasao opioid mo tiga tuga ma tiga.

AppliedVR ua uma ona fa'atuatuaina e le silia ma le 200 o faiga fa'alesoifua maloloina i le lalolagi. O le tekinolosi ua faʻaaogaina e le tusa ma le 60,000 tagata gasegase e oʻo mai i le taimi nei i le puleaina o tiga ma polokalame soifua maloloina.

OA MEA E AVEA MAI LENEI TUSI:

In its pivotal RCT studying the safety and efficacy of EaseVRx over an eight week period, participants in the EaseVRx group on average reported substantial improvements at post-treatment, including a 42% reduction in pain intensity.
A previous Johns Hopkins study in The Journal of Pain found that chronic pain can cumulatively cost as high as $635 billion a year — more than the annual costs of cancer, heart disease and diabetes combined.
Both studies concluded that a self-administered, skills-based VR treatment program was not only a feasible and scalable way to treat chronic pain, it also was effective at improving on multiple chronic pain outcomes.